Role of lysophosphatidic acid (LPA) and LPA1 receptor in the treatment of bone metastases in breast cancer

被引：0
|
作者：
Boucharaba, A.
Menaa, F.
Clezardin, P.
Peyruchaud, O.
机构：
[1] INSERM, U664, Mecanismes & Traitements Metastases Osseuses Tume, F-69372 Lyon 08, France
[2] Sidney Kimmel Canc Ctr, San Diego, CA 93121 USA
来源：
BULLETIN DU CANCER | 2007年 / 94卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
102
引用
收藏
页码：560 / 561
页数：2
相关论文
共 50 条
  • [1] Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1
    Avendaño-Vázquez, SEA
    García-Caballero, A
    García-Sáinz, JA
    BIOCHEMICAL JOURNAL, 2005, 385 : 677 - 684
  • [2] The type 1 lysophosphatidic acid receptor (LPA1): identification of a new therapeutic target for patients with bone metastases
    Peyruchaud, Olivier
    Boucharaba, Ahmed
    Serre, Claire-Marie
    Clezardin, Philippe
    CANCER RESEARCH, 2006, 66 (08)
  • [3] LYSOPHOSPHATIDIC ACID RECEPTOR LPA1 IS ESSENTIAL FOR DEVELOPMENT OF ARTHRITIS
    Miyabe, Y.
    Miyabe, C.
    Iwai, Y.
    Takayasu, A.
    Fukuda, S.
    Yokoyama, W.
    Nagai, J.
    Jona, M.
    Tokuhara, Y.
    Ohkawa, R.
    Albers, H. M.
    Ovaa, H.
    Aoki, J.
    Chun, J.
    Yatomi, Y.
    Ueda, H.
    Miyasaka, M.
    Miyasaka, N.
    Nanki, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 198 - 198
  • [4] Myelin alterations in absence of lysophosphatidic acid receptor LPA1
    Estivill-Torrus, G. G.
    Garcia-Diaz, B.
    Matas Rico, E.
    Gomez Conde, A. I.
    Riquelme, R.
    Varela Nieto, I.
    Jimenez, A. J.
    Leyva, L.
    Fernandez, O.
    Chin, J.
    Rodriguez de Fonseca, F.
    9TH EUROPEAN MEETING ON GLIAL CELLS IN HEALTH AND DISEASE, 2009, : 93 - 96
  • [5] MYELIN ALTERATIONS IN ABSENCE OF LYSOPHOSPHATIDIC ACID RECEPTOR LPA1
    Estivill-Torrus, G.
    Garcia-Diaz, B.
    Matas-Rico, E.
    Gomez-Conde, A., I
    Riquelme, R.
    Varela-Nieto, I
    Jimenez, A. J.
    Leyva, L.
    Fernandez, O.
    Chun, J.
    Rodriguez de Fonseca, F.
    GLIA, 2009, 57 (13) : S109 - S110
  • [6] Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells
    Guo, Rishu
    Kasbohm, Elizabeth A.
    Arora, Puneeta
    Sample, Christopher J.
    Baban, Babak
    Sud, Neetu
    Sivashanmugam, Perumal
    Moniri, Nader H.
    Daaka, Yehia
    ENDOCRINOLOGY, 2006, 147 (10) : 4883 - 4892
  • [7] Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer
    Liu, Wenjie
    Mousa, Amr A. K.
    Hopkins, Austin M.
    Wu, Yin Fang
    Thu, Kelsie L.
    Campbell, Michael
    Lees, Simon J.
    Ramachandran, Rithwik
    Hou, Jinqiang
    CHEMMEDCHEM, 2024, 19 (16)
  • [8] Free fatty acid receptor 4 agonists induce lysophosphatidic acid receptor 1 (LPA1) desensitization independent of LPA1 internalization and heterodimerization
    Meizoso-Huesca, Aldo
    Villegas-Comonfort, Socrates
    Teresa Romero-Avila, M.
    Adolfo Garcia-Sainz, J.
    FEBS LETTERS, 2018, 592 (15): : 2612 - 2623
  • [9] Experimental autoimmune encephalomyelitis in the absence of lysophosphatidic acid receptor LPA1
    Beatriz, Garcia-Diaz
    Isaac, Hurtado-Guerrero
    Ana Isabel, Gomez-Conde
    Laura, Leyva
    Oscar, Fernandez
    Jerold, Chun
    De Fonseca Fernando, Rodriguez
    Guillermo, Estivill-Torrus
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 31 - 32
  • [10] Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3
    Alcantara-Hernandez, Rocio
    Hernandez-Mendez, Aurelio
    Campos-Martinez, Gisselle A.
    Meizoso-Huesca, Aldo
    Adolfo Garcia-Sainz, J.
    PLOS ONE, 2015, 10 (10):
12345